Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-15 Purchase | 2022-12-19 08:09 am | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 1,200 | $2.5476 | $3,057 | 2,441 (Indirect Direct) | View |
| 2021-09-22 Purchase | 2021-09-23 4:10 pm | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 8,200 | $0.5851 | $4,798 | 384,507 (Indirect Direct) | View |
| 2021-05-07 Purchase | 2021-05-10 4:12 pm | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 6,000 | $0.832 | $4,992 | 376,307 (Indirect Direct) | View |
| 2020-04-17 Sale(A) | 2020-04-20 7:42 pm | Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO | 80,000 | $8.22 | $657,600 | 291,194 (Indirect Direct) | View |
| 2020-04-17 Sale | 2020-04-20 4:32 pm | Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO | 80,000 | $8.22 | $657,600 | 211,194 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-15 Option Award | 2022-06-17 4:10 pm | N/A N/A | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 39,473 | $0 | 49,664 (Direct) | View |
| 2021-12-22 Option Award | 2021-12-23 5:45 pm | N/A 2031-01-20 | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 821,168 | $0 | 1,177,884 (Direct) | View |
| 2021-12-15 Tax Withholding | 2021-12-23 5:45 pm | N/A N/A | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 18,636 | $0.31 | 1,177,884 (Direct) | View |
| 2021-12-05 Tax Withholding | 2021-12-14 6:27 pm | N/A N/A | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 9,155 | $0.35 | 375,352 (Direct) | View |
| 2021-04-20 Option Award(A) | 2021-05-17 4:04 pm | N/A 2031-04-20 | Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director | 38,012 | $0 | 38,012 (Direct) | View |
| 2021-04-20 Option Award | 2021-04-22 5:57 pm | N/A 2031-04-20 | Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director | 64,935 | $0 | 314,586 (Direct) | View |
| 2021-04-13 Option Award | 2021-04-15 9:07 pm | N/A 2031-04-13 | Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-01-20 Option Award | 2021-01-22 6:27 pm | N/A N/A | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 65,435 | $0 | 370,307 (Direct) | View |
| 2021-01-18 Exercise | 2021-01-20 7:54 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director | 5,000 | $0 | 249,651 (Direct) | View |
| 2021-01-18 Tax Withholding | 2021-01-20 7:54 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director | 6,816 | $3.03 | 249,651 (Direct) | View |
| 2021-01-02 Tax Withholding | 2021-01-05 5:04 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director | 5,599 | $3.09 | 251,467 (Direct) | View |
| 2020-12-05 Tax Withholding | 2020-12-09 5:45 pm | N/A N/A | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 83,015 | $1.14 | 304,872 (Direct) | View |
| 2020-12-05 Tax Withholding | 2020-12-09 5:43 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO | 34,128 | $2.3 | 257,066 (Direct) | View |
| 2020-04-17 Exercise(A) | 2020-04-20 7:42 pm | N/A 2024-12-16 | Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO | 80,000 | $0 | 291,194 (Direct) | View |
| 2020-04-17 Exercise(A) | 2020-04-20 7:42 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO | 80,000 | $2.47 | 291,194 (Direct) | View |
| 2020-01-27 Exercise | 2020-01-29 7:44 pm | N/A N/A | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 19,070 | $0 | 387,887 (Direct) | View |
| 2020-01-27 Tax Withholding | 2020-01-29 7:44 pm | N/A N/A | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 5,051 | $8.51 | 387,887 (Direct) | View |
| 2020-01-18 Exercise | 2020-01-22 5:44 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO | 5,000 | $0 | 296,194 (Direct) | View |
| 2020-01-18 Tax Withholding | 2020-01-22 5:44 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO | 5,552 | $16.38 | 296,194 (Direct) | View |
| 2020-01-02 Tax Withholding | 2020-01-03 4:51 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO | 4,945 | $17.53 | 291,746 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-09 6:27 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO | 93,550 | $0 | 296,691 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-09 6:18 pm | N/A 2029-12-05 | Baudax Bio Inc. | BXRX | HENWOOD GERALDINE President and CEO | 507,631 | $0 | 557,541 (Direct) | View |